Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL 
expression in activation-induced cell death

Liberman, A. C.; Refojo, D.; Antunica-Noguerol, M.; Holsboer, F.; Arzt, E.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death

MPS-Authors

/persons/resource/persons80487

Refojo, D.
Damian Refojo (Nachwuchsgruppenleiter), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80253

Arzt, E.
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Liberman, A. C., Refojo, D., Antunica-Noguerol, M., Holsboer, F., & Arzt, E. (2012). Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death. Molecular Immunology, 50(4), 220-235.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8C9C-6

Abstract

There is no abstract available